NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹1,477 Cr | ₹1,559 Cr | ₹1,191 Cr | ₹951 Cr | ₹937 Cr |
What is the latest Revenue of NEULAND LABORATORIES ?
Year | Revenue |
---|---|
Mar2025 | ₹1,477 Cr |
Mar2024 | ₹1,559 Cr |
Mar2023 | ₹1,191 Cr |
Mar2022 | ₹951 Cr |
Mar2021 | ₹937 Cr |
How is Revenue of NEULAND LABORATORIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹1,477 Cr | -5.24 | |
Mar2024 | ₹1,559 Cr | 30.84 | |
Mar2023 | ₹1,191 Cr | 25.25 | |
Mar2022 | ₹951 Cr | 1.51 | |
Mar2021 | ₹937 Cr | - |
Compare Revenue of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹18,689.4 Cr | 25.1% | 10.7% | 55.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 25.1% |
10.7% |
55.3% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses